Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Society of Nephrology. Clinical Journal

• Publication date

  2011-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2215/CJN.07110810PMID 21415311PMCID PMC3087765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dense deposit disease associated with monoclonal gammopathy of undetermined significance.

  2010influential reference
• C3 glomerulopathy: a new classification

  2010cited by this paper
• Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.

  2010cited by this paper
• Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.

  2009cited by this paper
• Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients.

  2009cited by this paper
• Complement regulators and inhibitory proteins

  2009cited by this paper
• C3 deposition glomerulopathy due to a functional factor H defect.

  2009cited by this paper
• Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.

  2009cited by this paper
• Marfan syndrome, MPGN, and bacterial endocarditis.

  2008cited by this paper
• Cryoglobulinemia and renal disease

  2008cited by this paper
• New approaches to the treatment of dense deposit disease.

  2007cited by this paper
• Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration.

  2007cited by this paper
• Acute renal failure due to mesangial proliferative glomerulonephritis in a pregnant woman with primary Sjögren’s syndrome

  2006cited by this paper
• Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome

  2006cited by this paper
• Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)

  2005cited by this paper
• The Role of Complement in Cryoglobulin-Induced Immune Complex Glomerulonephritis1

  2005cited by this paper
• Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.

  2005cited by this paper
• The classification of glomerulonephritis in systemic lupus erythematosus revisited.

  2004cited by this paper
• The classification of glomerulonephritis in systemic lupus erythematosus revisited.

  2004cited by this paper
• A statistical model for identifying proteins by tandem mass spectrometry.

  2003cited by this paper
• Glomerulonephritis after ventriculo-atrial shunt.

  1995cited by this paper
• Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan.

  1995cited by this paper
• Secondary membranoproliferative glomerulonephritis.

  1995cited by this paper
• Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritis factor and persistently low complement C3 and C5

  1992cited by this paper
• Incorporation of SP-40,40 into the soluble membrane attack complex (SMAC, SC5b-9) of complement.

  1990cited by this paper

• The role of B lymphocyte subsets in nephrotic syndrome: functions, mechanisms, clinical significance and future perspectives

  2025cites this paper
• Autoantibodies Against Factor B and Factor H Without Pathogenic Effects in a Patient with Immune Complex-Mediated Membranoproliferative Glomerulonephritis

  2025cites this paper
• Acquired drivers of C3 glomerulopathy

  2025cites this paper
• Kidney transplantation in children and adolescents with C3 glomerulopathy or immune complex membranoproliferative glomerulonephritis: a real-world study within the CERTAIN research network

  2024cites this paper
• Association of monoclonal gammopathy of undetermined significance and C3 glomerulopathy

  2023cites this paper
• Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study

  2023cites this paper
• Renal injury in scleromyxoedema due to monoclonal gammopathy associated C3 glomerulonephritis

  2022cites this paper
• Results from a national-wide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy.

  2022cites this paper
• The susceptibility of the kidney to alternative pathway activation—A hypothesis

  2022cites this paper
• Pathogenetic and morphological features in certain types of primary glomerulonephritis

  2021cites this paper
• C3 glomerulopathy and atypical hemolytic uremic syndrome: an updated review of the literature on alternative complement pathway disorders

  2021cites this paper
• Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys

  2021cites this paper
• C4d at Crossroads Between Post-Infectious Glomerulonephritis and C3 Glomerulopathy

  2021cites this paper
• Clinical Presentation, Renal Histopathological Findings, and Outcome in Patients with Monoclonal Gammopathy and Kidney Disease

  2021cites this paper
• Clinical Presentation and Renal Histopathological Findings in Patients with Monoclonal Gammopathy and Kidney Disease

  2020cites this paper
• Complement-mediated kidney diseases.

  2020cites this paper
• Glomerularne bolesti prije i nakon transplantacije bubrega

  2020cites this paper
• Glomerular diseases before and after kidney transplantation

  2020cites this paper
• C3-glomerulonephritis in New Zealand – a case series

  2020cites this paper
• Recurrent Glomerulonephritis after Renal Transplantation: The Clinical Problem

  2020cites this paper
• Membranoproliferative glomerulonephritis

  2019cites this paper
• Poor allograft outcome in Indian patients with post-transplant C3 glomerulopathy

  2019cites this paper
• Outcome of C3 glomerulopathy patients: largest single-centre experience from South Asia

  2019cites this paper
• Analytical validation of an alternative method to quantify specific antibodies in 3 applications.

  2019cites this paper
• Re-evaluation of primary membranoproliferative glomerulonephritis from a viewpoint of C3 glomerulopathy

  2019cites this paper
• Membranoproliferative Glomerulonephritis, Adult

  2019cites this paper
• Glomerular Complement Factor H–Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment

  2019cites this paper
• Utility of plasma exchange in early recurrent C3 glomerulopathy

  2019cites this paper
• Recurrent and de novo Glomerulonephritis After Kidney Transplantation

  2019cites this paper
• Glomérulopathies à dépôts de C3

  2019cites this paper
• Pathology of C3 Glomerulopathy

  2019cites this paper
• Chapter 7 C 3 Glomerulopathy

  2019cites this paper
• Gr upSM Primary Glomerulonephritis as Cause of Graft Disease after Renal Transplantation

  2018cites this paper
• C3 Glomerulopathy

  2018cites this paper
• The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.

  2018cites this paper
• Diseases of complement dysregulation—an overview

  2018cites this paper
• Treating C3 glomerulopathy with eculizumab

  2018cites this paper
• The role of the alternative pathway of complement activation in glomerular diseases

  2018cites this paper
• Genetic and acquired abnormalities in C3 glomerulopathy and primary immune complex-mediated MPGN

  2018cites this paper
• Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy

  2018cites this paper
• C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic

  2018cites this paper
• C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.

  2018cites this paper
• Complement-mediated renal diseases after kidney transplantation - current diagnostic and therapeutic options in de novo and recurrent diseases

  2018cites this paper
• Case Report of Spontaneous Remission of Biopsy-Proven Idiopathic Immune Complex-Mediated Membranoproliferative Glomerulonephritis

  2017cites this paper
• Cryoglobulinemic Glomerulonephritis: A Case Report

  2017cites this paper
• Use of C4d as a diagnostic tool to classify membranoproliferative glomerulonephritis.

  2017cites this paper
• C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.

  2017cites this paper
• C3 glomerulonephritis with a severe crescentic phenotype

  2017cites this paper
• Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.

  2017influential citation
• [Changes in the complement system in membranoproliferative glomerulonephritis].

  2017cites this paper
• C3 glomerulopathy: exploring the role of the glomerular micro-environment in disease pathogenesis

  2017cites this paper
• Overview of Laboratory Testing and Clinical Presentations of Complement Deficiencies and Dysregulation.

  2016cites this paper
• Diagnosis of complement alternative pathway disorders.

  2016cites this paper
• Complement abnormalities in membranoproliferative glomerulonephritis and C3 glomerulopathy

  2016cites this paper
• Primary glomerulonephritides.

  2016cites this paper
• Understanding the complement‐mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies

  2016influential citation
• C3 glomerulopathy and current dilemmas

  2016cites this paper
• Characterization of C3 in C3 glomerulopathy

  2016cites this paper
• Autoantibodies against alternative complement pathway proteins in renal pathologies.

  2016cites this paper
• C 3 Glomerulopathy and Therapeutic Potential of C 5 Complement Inhibitors

  2016cites this paper
• Spectrum of manifestations of monoclonal gammopathy-associated renal lesions

  2016cites this paper
• Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN.

  2016cites this paper
• CFHR2‐rs2986127 as a genetic protective marker for acute anterior uveitis in Chinese patients

  2016cites this paper
• A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H.

  2016cites this paper
• A novel PIK3CD C896T mutation detected in bilateral sudden sensorineural hearing loss using next generation sequencing: An indication of primary immunodeficiency☆

  2016cites this paper
• C3 glomerulonephritis and autoimmune disease: more than a fortuitous association?

  2016cites this paper
• Anti-complement-factor H-associated glomerulopathies

  2016cites this paper
• REGULATION OF COMPLEMENT ACTIVATION ON SURFACES: Towards better understanding of atypical hemolytic uremic syndrome

  2016cites this paper
• C3 Glomerulopathy and Therapeutic Potential of C5 Complement Inhibitors

  2016cites this paper
• Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.

  2016cites this paper
• Autoantibodies against alternative complement pathway proteins in renal pathologies.

  2016cites this paper
• C3 mesangial proliferative glomerulonephritis initially presenting with atypical hemolytic uremic syndrome: a case report

  2016cites this paper
• Complement regulation: physiology and disease relevance

  2015cites this paper
• Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience

  2015cites this paper
• Eculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis

  2015cites this paper
• The Development of Autoimmune Membrano-Proliferative Glomerulonephritis (Type II) In a Female Patient with Serological Combined Autoantibodies against Complement 3b and Factor B: Case Report

  2015cites this paper
• Familial C3 glomerulonephritis associated with mutations in the gene for complement factor B.

  2015cites this paper
• Advances in the Understanding of Complement Mediated Glomerular Disease: Implications for Recurrence in the Transplant Setting

  2015cites this paper
• C4d as a Diagnostic Tool in Proliferative GN.

  2015cites this paper
• A case of C3 glomerulonephritis successfully treated with eculizumab

  2015cites this paper
• Incidence and profile of C3 Glomerulopathy: A single center study

  2015cites this paper
• Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.

  2015cites this paper
• Complement involvement in kidney diseases: From physiopathology to therapeutical targeting.

  2015cites this paper
• Проект современной классификации гломерулонефрита у детей

  2015cites this paper
• C3 Glomerulonephritis Associated with Monoclonal Gammopathy

  2015cites this paper
• Uremic Syndrome: One Target, Two Diseases Glomerulopathies and in Atypical Hemolytic Factor H Autoantibodies in C3 - Anti

  2015cites this paper
• THE COMPLEMENT SYSTEM AND GLOMERULAR KIDNEY DISEASES: ETIOPATHOGENESIS, DIAGNOSTICS AND TREATMENT

  2015influential citation
• Complement-mediated glomerular injury in children

  2015cites this paper
• Membranoproliferative glomerulonephritis and C3 glomerulonephritis: Frequency, clinical features, and outcome in children

  2015cites this paper
• Anti–Factor H Autoantibodies in C3 Glomerulopathies and in Atypical Hemolytic Uremic Syndrome: One Target, Two Diseases

  2015cites this paper
• Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience

  2015cites this paper
• Assessment of Treatment Response of Iraqi Patients with Membranoproliferative Faiz Rashid Abayechi Glomerulonephritis with Emphasis on Renal Function and Proteinuria Regression

  2015cites this paper
• C3 Glomerulopathy: The Genetic and Clinical Findings in Dense Deposit Disease and C3 Glomerulonephritis

  2014cites this paper
• [C3 glomerulopathy].

  2014cites this paper
• Reanalysis of membranoproliferative glomerulonephritis patients according to the new classification: a multicenter study☆

  2014cites this paper
• Circulating complement levels and C3 glomerulopathy.

  2014cites this paper
• A novel CFHR5 mutation associated with C3 glomerulonephritis in a Turkish girl

  2014cites this paper
• Complement-Mediated Glomerular Diseases

  2014cites this paper
• New classification of membranoproliferative glomerulonephritis: a good start but a long way to go

  2014cites this paper
• Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?

  2014cites this paper